Evidence map›Paper›PMID 34181079›Full record

ArticleActa diabetologica2021

Letter to the Editor on Type 1 diabetes onset triggered by COVID-19.

Mentari Maratus Sholihah, Taufik Ridwan Hadi Kusuma, Muhammad Ifham Hanif, Nurhasan Agung Prabowo

4 registry-linked trialsAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta diabetologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05766176 completednot on this mapstarted 2022, after this paper: background citation

Study of the Effectiveness of The COVID-19 Vaccine

TypeobservationalSponsorUniversitas Sebelas MaretRan2022 to 2022Enrolled100ConditionsCOVID-19ArmsCOVID-19 Antibody
NCT05921058 phase1 / phase2completednot on this mapstarted 2022, after this paper: background citation

The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients

TypeinterventionalSponsorUniversitas Sebelas MaretRan2022 to 2023Enrolled15ConditionsLupus ErythematosusArmsSecretome, Placebo
NCT05925647 phase1 / phase2completednot on this mapstarted 2022, after this paper: background citation

The Effects of Mesenchymal Stem Cell Secretome in Rheumatoid Arthritis Patients

TypeinterventionalSponsorUniversitas Sebelas MaretRan2022 to 2023Enrolled15ConditionsRheumatoid ArthritisArmsMessenchymal stem cell secretome, Placebo
NCT05943405 completednot on this mapstarted 2022, after this paper: background citation

The Disease Severity In Patients With Psoriasis

TypeobservationalSponsorUniversitas Sebelas MaretRan2022 to 2022Enrolled33ConditionsPsoriasis
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Mentari Maratus SholihahFaculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.
Taufik Ridwan Hadi KusumaFaculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.
Muhammad Ifham HanifFaculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. muhammadifhamhanif@gmail.com.ORCID 0000-0003-1788-7982
Nurhasan Agung PrabowoDepartment of Internal Medicine, Universitas Sebelas Maret Hospital, Surakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34181079
PMCPMC8236735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.